The Patent Finder

Vical Incorporated

Also on record
Records under this name other than patents Vical Incorporated holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Vical Incorporated

PatentTitleStatus Expires Confidence
US 8,852,610Compositions and methods for vaccinating against HSV-2
Lapsed on the fee record
Ended Oct 7, 2022 · From the USPTO record
Lapsed on the fee recordEnded Oct 7, 2022From the USPTO record
US 8,852,611Compositions and methods for vaccinating against HSV-2
Lapsed on the fee record
Ended Oct 7, 2022 · From the USPTO record
Lapsed on the fee recordEnded Oct 7, 2022From the USPTO record
US 8,840,903Compositions and methods for vaccinating against HSV-2
Lapsed on the fee record
Ended Sep 23, 2022 · From the USPTO record
Lapsed on the fee recordEnded Sep 23, 2022From the USPTO record
US 8,840,904Compositions and Methods for Vaccinating Against HSV-2
Lapsed on the fee record
Ended Sep 23, 2022 · Low confidence
Lapsed on the fee recordEnded Sep 23, 2022Low confidence
US 8,834,894Compositions and Methods for Vaccinating Against HSV-2
Lapsed on the fee record
Ended Sep 16, 2022 · Medium confidence
Lapsed on the fee recordEnded Sep 16, 2022Medium confidence
US 8,828,408Compositions and Methods for Vaccinating Against HSV-2
Lapsed on the fee record
Ended Sep 9, 2022 · Low confidence
Lapsed on the fee recordEnded Sep 9, 2022Low confidence
US 8,821,890Influenza virus vaccine composition and methods of use
Lapsed on the fee record
Ended Sep 2, 2022 · From the USPTO record
Lapsed on the fee recordEnded Sep 2, 2022From the USPTO record
US 7,785,603Influenza virus vaccine composition and methods of use
Lapsed on the fee record
Ended Aug 31, 2022 · From the USPTO record
Lapsed on the fee recordEnded Aug 31, 2022From the USPTO record
US 7,700,350Recombinant vector containing infectious human cytomegalovirus genome with preserved wild-type characteristics of clinical isolates
Lapsed on the fee record
Ended Apr 20, 2022 · From the USPTO record
Lapsed on the fee recordEnded Apr 20, 2022From the USPTO record
US 8,673,317Codon-optimized polynucleotide-based vaccines against human Cytomegalovirus infection
Lapsed on the fee record
Ended Mar 18, 2022 · From the USPTO record
Lapsed on the fee recordEnded Mar 18, 2022From the USPTO record
10 of 74 patents shown.
Pro members see all 74.
Pro members: see all 74 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited